Lai Tham

658 total citations
21 papers, 508 citations indexed

About

Lai Tham is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Lai Tham has authored 21 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Lai Tham's work include Diabetes Treatment and Management (12 papers), Pancreatic function and diabetes (5 papers) and Diabetes Management and Research (4 papers). Lai Tham is often cited by papers focused on Diabetes Treatment and Management (12 papers), Pancreatic function and diabetes (5 papers) and Diabetes Management and Research (4 papers). Lai Tham collaborates with scholars based in United States, Singapore and China. Lai Tham's co-authors include Boon Cher Goh, Richie Soong, Jia Guo, A NAFZIGER, Serene M. L. Lee, Lu Wang, Kenneth Mace, Helle Linnebjerg, Soo Chin Lee and Harry Haber and has published in prestigious journals such as The Lancet, Clinical Pharmacology & Therapeutics and Clinical Pharmacokinetics.

In The Last Decade

Lai Tham

19 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lai Tham United States	11	198	153	148	124	98	21	508
Mark Goldammer Germany	7	94 0.5×	203 1.3×	176 1.2×	84 0.7×	51 0.5×	12	479
Hanna Nylén Sweden	10	117 0.6×	244 1.6×	131 0.9×	78 0.6×	104 1.1×	12	423
Christine Reynolds United States	11	87 0.4×	62 0.4×	92 0.6×	65 0.5×	57 0.6×	15	420
Petra Obermayer–Straub Germany	23	256 1.3×	263 1.7×	177 1.2×	164 1.3×	183 1.9×	33	1.4k
Shazia Ali United States	9	83 0.4×	169 1.1×	216 1.5×	259 2.1×	206 2.1×	15	756
Mark A. Milad United States	15	187 0.9×	189 1.2×	175 1.2×	126 1.0×	333 3.4×	24	966
Shuichi Fukuen Japan	6	66 0.3×	226 1.5×	150 1.0×	121 1.0×	28 0.3×	6	419
Ida Robertsen Norway	16	180 0.9×	100 0.7×	85 0.6×	61 0.5×	247 2.5×	38	661
Fabiana Dalla Vecchia Genvigir Brazil	15	69 0.3×	117 0.8×	133 0.9×	129 1.0×	238 2.4×	29	526
William J. Jusko United States	13	92 0.5×	118 0.8×	90 0.6×	190 1.5×	59 0.6×	17	607

Countries citing papers authored by Lai Tham

Since Specialization

Citations

This map shows the geographic impact of Lai Tham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lai Tham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lai Tham more than expected).

Fields of papers citing papers by Lai Tham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lai Tham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lai Tham. The network helps show where Lai Tham may publish in the future.

Co-authorship network of co-authors of Lai Tham

This figure shows the co-authorship network connecting the top 25 collaborators of Lai Tham. A scholar is included among the top collaborators of Lai Tham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lai Tham. Lai Tham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhattachar, Shobha, Lai Tham, Li Yan, et al.. (2025). Mazdutide reduces body weight in adults with overweight or obesity: A high‐dose Phase 1 trial. Diabetes Obesity and Metabolism. 27(11). 6460–6469.

Posada, Maria M., Karen Schneck, Bridget L. Morse, et al.. (2025). A Combined Modeling Approach to Predict the Effect of Gastric Emptying Delay on the Pharmacokinetics of Small Molecules. CPT Pharmacometrics & Systems Pharmacology. 14(12). 2026–2039.

Briere, Daniel A., Hongchang Qu, Katherine Lansu, et al.. (2025). Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept. Molecular Metabolism. 102. 102271–102271. 4 indexed citations

Billings, Liana K., Stanley H. Hsia, Harold Bays, et al.. (2025). Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial. The Lancet. 406(10520). 2631–2643. 1 indexed citations

Tham, Lai, Hiddo J.L. Heerspink, Xiaojun Wang, et al.. (2024). Volenrelaxin (LY3540378) increases renal plasma flow: a randomized Phase 1 trial. Nephrology Dialysis Transplantation. 40(1). 109–122. 3 indexed citations

Lim, Jean K., et al.. (2023). Practical Applications of a Nausea and Vomiting Model in the Clinical Development of Additional Doses of Dulaglutide. The Journal of Clinical Pharmacology. 64(2). 215–226. 1 indexed citations

Zhang, Yifei, Yiming Li, Xia Zhao, et al.. (2021). Pharmacokinetics, Pharmacodynamics, and Safety of Dulaglutide After Single or Multiple Doses in Chinese Healthy Subjects and Patients with T2DM: A Randomized, Placebo-Controlled, Phase I Study. Advances in Therapy. 39(1). 488–503. 7 indexed citations

Tham, Lai, Kevin M. Pantalone, Kathleen Dungan, et al.. (2021). A model‐based simulation of glycaemic control and body weight when switching from semaglutide to 3.0‐ and 4.5‐mg doses of once‐weekly dulaglutide. Diabetes Obesity and Metabolism. 24(2). 302–311. 11 indexed citations

Liu, Hui, Feng Wang, Yongjia Ji, et al.. (2021). A Euglycemic Glucose Clamp Study to Evaluate the Bioavailability of LY2963016 Relative to Insulin Glargine in Healthy Chinese Subjects. Clinical Pharmacology in Drug Development. 10(12). 1452–1459. 3 indexed citations

10.

Frías, Juan P., Alan Wynne, Beata Matyjaszek‐Matuszek, et al.. (2019). Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo‐controlled trial in patients with type 2 diabetes using metformin. Diabetes Obesity and Metabolism. 21(9). 2048–2057. 35 indexed citations

11.

Morse, Bridget L., Maria M. Posada, Jessica Rehmel, et al.. (2019). Physiologically‐Based Pharmacokinetic Modeling of Atorvastatin Incorporating Delayed Gastric Emptying and Acid‐to‐Lactone Conversion. CPT Pharmacometrics & Systems Pharmacology. 8(9). 664–675. 25 indexed citations

12.

Schneck, Karen, et al.. (2018). Toward Better Understanding of Insulin Therapy by Translation of a PK‐PD Model to Visualize Insulin and Glucose Action Profiles. The Journal of Clinical Pharmacology. 59(2). 258–270. 4 indexed citations

13.

Tham, Lai, et al.. (2017). Modeling Pharmacokinetic Profiles of Insulin Regimens to Enhance Understanding of Subcutaneous Insulin Regimens. The Journal of Clinical Pharmacology. 57(9). 1126–1137. 12 indexed citations

14.

Zhang, Xin, Laiyi Chua, C. Steven Ernest, et al.. (2017). Dose/Exposure‐Response Modeling to Support Dosing Recommendation for Phase III Development of Baricitinib in Patients with Rheumatoid Arthritis. CPT Pharmacometrics & Systems Pharmacology. 6(12). 804–813. 21 indexed citations

15.

Keller, Jutta, Michael Trautmann, Harry Haber, et al.. (2012). Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects. Regulatory Peptides. 179(1-3). 77–83. 52 indexed citations

16.

Zhao, Xia, Yuan Cui, Yanling Zhou, et al.. (2008). Exenatide pharmacokinetics in healthy Chinese subjects. International Journal of Clinical Pharmacology and Therapeutics. 46(9). 459–465. 7 indexed citations

17.

Soo, Ross A., Ling Zhi Wang, P Y Chong, et al.. (2008). Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients. Lung Cancer. 63(1). 121–127. 56 indexed citations

18.

Tham, Lai, Michael J. Holmes, Marion Aw, et al.. (2006). Population Pharmacokinetics of Tacrolimus in Whole Blood and Plasma in Asian Liver Transplant Patients. Clinical Pharmacokinetics. 45(1). 59–75. 62 indexed citations

19.

Xiang, Xiaoqiang, Srinivasa Rao Jada, Lu Fan, et al.. (2006). Pharmacogenetics of SLCO1B1 gene and the impact of *1b and *15 haplotypes on irinotecan disposition in Asian cancer patients. Pharmacogenetics and Genomics. 16(9). 683–691. 66 indexed citations

20.

Tham, Lai, Boon Cher Goh, A NAFZIGER, et al.. (2006). A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9. Clinical Pharmacology & Therapeutics. 80(4). 346–355. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact